Embed Size (px)
DESCRIPTION
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousands by the following Dosage Forms: Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid & Semi-solid Dosage Forms (Syrups, Suspensions, Gels, Creams & Ointments). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 92 companies including many key and niche players such as - AAIPharma Services Corporation, Aenova Group, Ajinomoto Althea, Inc., Albany Molecular Research, Inc., Dishman.
Citation preview
“Pricing Pressures and Shrinking Margins Drive the Global Pharmaceutical Contract Manufacturing Market”
“Pricing Pressures and Shrinking Margins Drive the Global Pharmaceutical Contract Manufacturing Market”
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
For more details
June 2014 ReleaseJune 2014 Release
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
Global market for Pharmaceutical Contract Manufacturing (PCM) is forecast to reach US$23.4 billion by 2020, spurred by pricing pressures and shrinking margins aggravated by patent expiries, regulatory and competitive pressures, and emergence of generics to replace blockbuster drugs nearing patent expiries. Growth in Asia-Pacific, the fastest growing market, is led by robust healthcare spending in China, India, Indonesia, Malaysia, Philippines, and Thailand.
• Boehringer Ingelheim GmbH
• Catalent Pharma Solutions Inc.
• DPx Holdings B.V.
• Famar Health Care Services
• Hospira Inc.
• Jubilant Life Sciences Limited
• Kemwell Biopharma Pvt. Ltd.
• Lonza Group Ltd.
• NextPharma Technologies Holding Ltd.
Major Players…US$23.4 Billion
2014 2015 2016 2017 2018 202020192013
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
• PCM for Vaccines: An Untapped Market
With Strong Growth Potential
• Manufacturing Challenges Posed by the
Complex Drug Structure of Biologics to
Benefit Market Growth by Amplifying the
Need for Specialized Manufacturing
Expertise
• Declining Margins on Drugs Spurs Demand
for Contract Manufacturing Services
• Rise of Small Biotech Companies Lacking
Manufacturing Infrastructure Accelerates
the Need for Third Party Services
• Injectable-Dose Formulations: An
Emerging Opportunity for Pharma
Contract Manufacturers
Snapshot Summary of Trends & Drivers
• The United States represents the largest
regional market worldwide, while Asia-
Pacific ranks as the fastest growing
market with a CAGR of 9.7% over the
analysis period.
USA
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
GIA’s Actionable Research Insights
Market Analytics Market Profiling Competitive Intelligence
• Estimates and Forecasts for 2013-2020
• Geographic Regions Analyzed – The United States, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
• Dosage Forms Analyzed - Injectables, Solid Dosage Forms, and Liquid & Semi-solid Dosage Forms.
• Market Trends & Issues
• Growth Drivers & Enablers
• Growth Inhibitors
• Opportunities and Challenges
• Recent Industry Activity
• Product Innovations & Trends
• Market Analyses, Facts,
Figures & Forecasts
• Coverage of Major & Niche
Players
• Comprehensive Geographic
Coverage
• Extensive Product Coverage
• 92 major and niche players covered
To browse full report table of contents, please
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.Telephone: 408-528-9966Fax: 408-528-9977 Email: [email protected] Site: http://www.strategyr.com/
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
The research report titled “Pharmaceutical Contract Manufacturing: A Global Strategic Business
Report” published by Global Industry Analysts, Inc., is now available for purchase online. To view
report excerpts and the full table of contents (TOC) and to sign up for a comprehensive
complimentary review of our research program including details on methodology, secondary and
primary sources and summary of research findings, please visit –
http://www.strategyr.com/Pharmaceutical_Contract_Manufacturing_Market_Report.asp
